A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.

NCT01958957 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

6300

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Ginkgolides Meglumine Injection

Sponsor

Jiangsu Kanion Pharmaceutical Co., Ltd

Collaborators

[object Object]